News Archives - Page 395 of 735

MondayAug 16, 2021 9:00 am

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) Advancing Hybrid and Virtual Events Through Innovation

NexTech announced a multi-event deal with FENEX to facilitate the fenestration sector’s first virtual exhibition The deal, which is worth approximately $185,000, will showcase NexTech’s ability to support and connect buyers and sellers in a B2B environment It also shows NexTech’s commitment to advancing hybrid and virtual events through innovation NexTech is also scheduled to present at the next OTCQB Venture Virtual Investor Conference that is scheduled for Thursday, August 5, 2021 In July 2021, Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF) announced that it had closed a multi-event deal with FENEX for the fenestration sector’s first virtual exhibition platform.…

FridayAug 13, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Shares Insights on the Psychedelics Space on The Dealmaker Podcast

Mr. Greg McKee, CEO of Tryp Therapeutics, appeared on The Dealmaker Podcast to share insights on the company and the psychedelics industry During the interview, he discussed the potential of psychedelics in the treatment of PTSD and other mental disorders Greg also shared the challenges that the industry is facing currently, mostly to do with legislation McKee also shared how people can help the company and the industry by pushing for the decriminalization of psychedelics and taking part in clinical trials On August 2, 2021, the Dealmaker Podcast posted an interview with Greg McKee, the Chief Executive Officer (“CEO”) of…

FridayAug 13, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Bolsters its Advisory Board With The Appointment of Jerry White

Mind Cure Health Inc. announced Jerry White’s appointment into the company’s advisory board Mr. White brings a wealth of experience from his years of powering global movements and working with key leaders and personalities around the world MINDCURE forecasts that with Mr. White’s addition to the board, the company will be well-positioned to achieve bigger and better goals, all while working towards its overall vision of building mental wealth globally Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) announced that it has appointed Jerry White as an advisor to the company. Mr. White would be an excellent addition to…

FridayAug 13, 2021 9:00 am

SRAX Inc. (NASDAQ: SRAX) Returns to In-Person Format for 2021 LD Micro Main Event on October 12-14, 2021

SRAX will host 2021 LD Micro Main Event on October 12-14, 2021 Conference is set to be held in in-person format in Los Angeles as well as virtually, through the Sequire Virtual Events platform The conference builds on success from LD Micro Invitational, a three-day microcap conference held between June 8-10, 2021 SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, has announced that it will be hosting the 2021 LD Micro Main Event, both in-person in Los Angeles as well as virtually via its Sequire Virtual Events platform, on October 12-14, 2021 (https://ibn.fm/hq6RG). The…

ThursdayAug 12, 2021 11:30 am

Anpac Bio Continues Growth Trajectory

In recent years, advances in technology have led to demand for early cancer testing and screening methods that are less invasive and lower cost. Insurance companies have accepted that traditional testing methods are labor intensive and are not ideal as the first line of defense when screening and diagnosing cancer. This has opened a multi-billion-dollar market opportunity in discovering new solutions to tackle cancer and disease testing outside of traditional diagnostics that have been used for generations without any major upgrades or breakthroughs. AnPac Bio-Medical Science Co., Ltd. (ANPC.US), a biotechnology company focused on early cancer screening and detection as…

ThursdayAug 12, 2021 9:00 am

Streamlytics Is ‘One to Watch’

Streamlytics helps consumers get paid for their data through its proprietary Data Valuation algorithm The company is the largest first-party provider of African American data Streamlytics has a patent-pending new data standard, the Universal Data Interchange Format, that powers the company’s data unification The global alternative data market was valued at $1.06 billion in 2019 and is expected to grow at a CAGR of 40.1% to reach more than $8 billion by 2027 The global artificial intelligence market was valued at $62.35 billion in 2020 and is expected to achieve a CAGR of 40.2% from 2021 to 2028 Streamlytics is…

ThursdayAug 12, 2021 9:00 am

FingerMotion Inc. (FNGR) Schedules a Corporate Update Call for August 25 Against the Backdrop of Recent Positive Announcements

FingerMotion is planning to host a corporate update call on August 25 at 1 pm Eastern Time As part of the call, FNGR CEO Martin Shen is expected to cover recent developments, including the quarterly financial results, application to uplist to the NASDAQ, and plans for an upcoming annual meeting of shareholders A question-and-answer session is scheduled at the end of the call FingerMotion (OTCQX: FNGR), an evolving technology company with core competency in mobile payment solutions in China, as well as SMS/MMS, will be hosting a corporate update call scheduled for August 25, 2021, at 1 pm Eastern Time.…

ThursdayAug 12, 2021 9:00 am

Friendable Inc. (FDBL) Completes Rebranding Initiatives; CEO Talks Progress, Revenue and Growth Strategy, Market Opportunity in SmallCapVoice.com Interview

Friendable’s 120-day strategy is underway and encompasses several milestones, including the launch of a redesigned Fan Pass platform and new website for its core business The company recently announced it had completed several rebranding initiatives, including an updated corporate deck and new website for its Fan Pass livestream platform The rebranding comes on the heels of the launch of Fan Pass 2.0 and a recent SmallCapVoice.com interview in which Friendable CEO Robert A. Rositano Jr. discussed the company’s vision, progress so far, market opportunity, the new version of its Fan Pass platform, and revenue and growth strategy In a bid…

WednesdayAug 11, 2021 12:38 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Partial Results from Human Clinical Trial of DehydraTECH(TM)-Processed Cannabidiol for Hypertension

Clinical study HYPER-H21-1 evaluates the use of patented DehydraTECH(TM)-processed CBD for use against hypertension Hypertension is a primary or contributing factor in the death of almost 500,000 people per year, with approximately one in four adults aged 20 to 44 suffering from high blood pressure Initial results of the study show that blood pressure was reduced in both male and female volunteers, resulting in the reinforcement of pre-existing findings demonstrating that DehydraTECH delivers superior performance Lexaria plans on launching two additional clinical trials, for a total of three clinical trials in 2021 for the DehydraTECH-CBD with hypertension applications Lexaria (NASDAQ:…

Site Search

Company Search

Category: News

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) Advancing Hybrid and Virtual Events Through Innovation

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Shares Insights on the Psychedelics Space on The Dealmaker Podcast

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Bolsters its Advisory Board With The Appointment of Jerry White

SRAX Inc. (NASDAQ: SRAX) Returns to In-Person Format for 2021 LD Micro Main Event on October 12-14, 2021

Anpac Bio Continues Growth Trajectory

Streamlytics Is ‘One to Watch’

FingerMotion Inc. (FNGR) Schedules a Corporate Update Call for August 25 Against the Backdrop of Recent Positive Announcements

Friendable Inc. (FDBL) Completes Rebranding Initiatives; CEO Talks Progress, Revenue and Growth Strategy, Market Opportunity in SmallCapVoice.com Interview

Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Partial Results from Human Clinical Trial of DehydraTECH(TM)-Processed Cannabidiol for Hypertension

Market Basics

Newsletter Publishers

Public Companies